本页面由Tiger Trade Technology Pte. Ltd.提供服务

Regenxbio Inc

9.19
-0.1700-1.82%
盘后9.190.00000.00%17:17 EDT
成交量:36.57万
成交额:335.28万
市值:4.74亿
市盈率:-2.44
高:9.42
开:9.36
低:9.04
收:9.36
52周最高:16.19
52周最低:5.85
股本:5,161.30万
流通股本:4,299.86万
量比:0.61
换手率:0.85%
股息:- -
股息率:- -
每股收益(TTM):-3.7593
每股收益(LYR):-3.7593
净资产收益率:-107.00%
总资产收益率:-21.93%
市净率:4.62
市盈率(LYR):-2.44

数据加载中...

2024/06/03

重要事件披露

Form 8-K - Current report
2024/05/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/08

重要事件披露

Form 8-K - Current report
2024/03/11

重要事件披露

Form 8-K - Current report
2024/03/07

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/05

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/26

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/25

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/18

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]